£515.00

The 2023-2028 Outlook for Myasthenia Gravis in India

Price data last checked 75 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 16 days • 16 data points (No recent data available)

Historical
Generating forecast...
£515.00 £489.25 £499.55 £509.85 £520.15 £530.45 £540.75 26 January 2026 29 January 2026 02 February 2026 06 February 2026 10 February 2026

Price Distribution

Price distribution over 16 days • 1 price levels

Days at Price
16 days 0 4 8 12 16 £515 Days at Price

Price Analysis

Most common price: £515 (16 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 16 days

Product Specifications
Format
Paperback
ASIN
B0BGKZD5PH
Category
Books > Subjects
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
29 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India
96% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India

£515.00 04 Feb 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
96% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

£515.00 11 Jan 2026
The 2023-2028 Outlook for External Neurostimulation in India
96% match

The 2023-2028 Outlook for External Neurostimulation in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Vision Care in India
96% match

The 2023-2028 Outlook for Vision Care in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
96% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Statins in India
96% match

The 2023-2028 Outlook for Statins in India

£515.00 29 Jan 2026
The 2023-2028 Outlook for Motion Sickness Medications in India
96% match

The 2023-2028 Outlook for Motion Sickness Medications in India

£515.00 31 Jan 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in India
96% match

The 2023-2028 Outlook for Anti-Malarial Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in India
96% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in India

£515.00 27 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India

£515.00 31 Jan 2026
The 2023-2028 Outlook for COVID-19 Vaccines in India
96% match

The 2023-2028 Outlook for COVID-19 Vaccines in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Diabetic Neuropathy in India
96% match

The 2023-2028 Outlook for Diabetic Neuropathy in India

£515.00 13 Jan 2026
The 2023-2028 Outlook for Syringes in India
96% match

The 2023-2028 Outlook for Syringes in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Uveitis Drugs in India
96% match

The 2023-2028 Outlook for Uveitis Drugs in India

£515.00 01 Feb 2026
The 2023-2028 Outlook for Narcolepsy Drugs in India
96% match

The 2023-2028 Outlook for Narcolepsy Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in India
96% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in India
96% match

The 2023-2028 Outlook for Anti-Migraine Drugs in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in India
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India
96% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Endoscopic Stricture Management Devices in India
96% match

The 2023-2028 Outlook for Endoscopic Stricture Management Devices in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Motion Sickness Treatments in India
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Neurostimulation Devices in India
96% match

The 2023-2028 Outlook for Neurostimulation Devices in India

£515.00 21 Jan 2026
The 2023-2028 Outlook for Gram-Positive Bacterial Infections in India
96% match

The 2023-2028 Outlook for Gram-Positive Bacterial Infections in India

£515.00 16 Feb 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in India
96% match

The 2023-2028 Outlook for Macular Degeneration Treatments in India

£515.00 29 Jan 2026